SRPX is downregulated in PC compared to normal prostate or benign prostate hyperplasia (BPH) and is one of seven candidate genes identified that exhibit reduced expression and increased promoter methylation, a pattern characteristic of tumor suppressors (Kamdar et al., 2019). This evidence concerns the gene SRPX and benign prostatic hyperplasia.